Non-inferiority of GlaxoSmithKline Biologicals' influenza vaccine (GSK576389A) 1 container over 2 container presentation in adults aged 65 years and over.

Trial Profile

Non-inferiority of GlaxoSmithKline Biologicals' influenza vaccine (GSK576389A) 1 container over 2 container presentation in adults aged 65 years and over.

Completed
Phase of Trial: Phase II

Latest Information Update: 19 Dec 2016

At a glance

  • Drugs GSK 576389A (Primary) ; Influenza virus vaccine
  • Indications Influenza virus infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 16 Oct 2008 Primary outcome added as reported by ClinicalTrials.gov.
    • 12 Oct 2008 Actual number of patients (1596) added as reported by CT.gov
    • 16 Nov 2007 Status changed from recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top